Regulatory Due Diligence Becomes More Critical in a “Hot” Year for Deals in the FDA Space
FDA Law Blog
JANUARY 8, 2024
If this all holds true, it will follow the upward trend of the 2023 year in deals. In a “hot” deal market, its worthwhile reiterating the fundamentals of regulatory due diligence that don’t change, no matter how attractive the deal or how short the window is to seize the opportunity. Not every diligence issue is a dealbreaker.
Let's personalize your content